2019 Life Sciences Dealmaking Symposium


Opportunities abound for dealmakers who can navigate the ever-changing global life sciences deal landscape. However, the transformative transactions shaping today’s hottest life sciences growth sectors also can present new—and sometimes daunting—challenges for your organization. Join us for this one-day conference, now in its eighth year, focused on all aspects of dealmaking in the life sciences industry. New this year will be two afternoon tracks, one for investors and BD professionals, and the other for in-house counsel in the life sciences industry.

This “must attend” event will feature:

  • Access to 300+ life sciences executives and investors
  • Best practices from seasoned dealmakers, industry executives and technical experts
  • Insight on the critical business, transactional and regulatory issues that impact investment growth and profitability

Registration Information

October 15-16 2019


The Royal Sonesta
40 Edwin H Land Blvd,
Cambridge, MA 02142
View Map

Keynote Speaker

Scott Gottlieb, M.D.

23rd Commissioner of the Food & Drug Administration

Scott Gottlieb will join McDermott FDA Practice Co-Chair Vernessa Pollard for a lunchtime fireside chat.

Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety.


For more information and sponsorship opportunities, please contact Laura McAllister or Angus McQuilken.

Mehr erfahren

McDermott Event / April 28-29, 2022

Life Sciences Dealmakers Symposium

Virtual / McDermott Event / January 10-14, 2022

2022 J.P. Morgan Healthcare Conference

Virtual Event / Event Sponsoring / December 1-3, 2021

EIT Health Catapult Awards

Webinar / Externe Vorträge / November 23, 2021

Health & Cybersecurity | Best Practice Post COVID-19

Virtual Conference / Externe Vorträge / November 4, 2021

65th Annual IP Law Conference | Vaccines, IP and Global Equity